ATROPINE SULFATE
Generic: ATROPINE SULFATE
Accord Healthcare Inc.Manufacturer
ENDOTRACHEAL, INTRAMEDULLARY, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRoute
ATROPINE SULFATEActive Substance
2021-03-19Original Approval
ATROPINE SULFATE is FDA application ANDA213424, sponsored by ACCORD HLTHCARE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2017-10-20
diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1),SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Class II2026-07-24
Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, gla
Class II2023-07-03
Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for: APresence of Particulate Matter: Particulate matter identified as fiber.
Class I2023-12-21
Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL SPresence of Particulate Matter; identified as glass
Class II2022-04-13
Isopto Atropine (atropine sulfate ophthalmic solution) 1%, 5mL bottle, MFG: Alcon Surgical, NDC 0065-0303-55cGMP deviations: Temperature abuse
Class III2024-12-16
Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. SomerFailed Impurities/Degradation Specifications
Top Reported Reactions
1
DRUG INEFFECTIVE
998 reports
2
OFF LABEL USE
829 reports
3
DIARRHOEA
769 reports
4
NAUSEA
746 reports
5
FATIGUE
644 reports
6
DEATH
590 reports
7
HYPOTENSION
584 reports
8
PAIN
546 reports
9
DYSPNOEA
502 reports
10
VOMITING
497 reports